Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Brain research. Brain research protocols

• Publication date

  1997-08-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/S1385-299X(96)00037-2PMID 9385062
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease.

  1995cited by this paper
• Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats.

  1995cited by this paper
• Systemic 3-nitropropionic acid: long-term effects on locomotor behavior.

  1994cited by this paper
• Cell transplantation for central nervous system disorders.

  1994cited by this paper
• The quinolinic acid model of Huntington's disease: locomotor abnormalities.

  1989cited by this paper
• Nocturnal paroxysmal dystonia.

  1986cited by this paper
• Automated measurement of multivariate locomotor behavior in rodents.

  1985cited by this paper
• Effects of intrastriatal injections of the cholinergic neurotoxin AF64A on spontaneous nocturnal locomotor behavior in the rat.

  1984cited by this paper
• Scientific approaches to Huntington's disease.

  1984cited by this paper
• Learning impairments following selective kainic acid-induced lesions within the neostriatum of rats.

  1981cited by this paper
• Relationship of some open-field behaviors to amygdaloid kindled convulsions in Wistar rats.

  1979cited by this paper
• Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract.

  1978cited by this paper

• Natural products proposed for the management of Huntington’s disease (HD): a comprehensive review

  2025cites this paper
• Exploring the role of Cdk5 on striatal synaptic plasticity in a 3-NP-induced model of early stages of Huntington’s disease

  2024cites this paper
• From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research

  2023cites this paper
• Locomotor Behavior and Memory Dysfunction Induced by 3-Nitropropionic Acid in Adult Zebrafish: Modulation of Dopaminergic Signaling

  2023cites this paper
• Modeling Huntington's disease: An insight on in-vitro and in-vivo models.

  2023cites this paper
• The boundlessness of behavioral neuroscience: A look across 30 years.

  2022cites this paper
• Modulation of adenosine signaling reverses 3-nitropropionic acid-induced bradykinesia and memory impairment in adult zebrafish.

  2022cites this paper
• Inhibition of Brain GTP Cyclohydrolase I Attenuates 3-Nitropropionic Acid-Induced Striatal Toxicity: Involvement of Mas Receptor/PI3k/Akt/CREB/ BDNF Axis

  2021cites this paper
• Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia

  2021cites this paper
• Influence of 3-nitropropionic acid on physiological and behavioral responses in zebrafish larvae and adults.

  2020cites this paper
• Transplantation of Human Dental Pulp Stem Cells Compensates for Striatal Atrophy and Modulates Neuro-inflammation in 3-nitropropionic Acid Rat Model of Huntington's Disease.

  2020cites this paper
• Peroxisomal Malfunction Caused by Mitochondrial Toxin 3-NP: Protective Role of Oxytocin

  2019cites this paper
• Striatal Neurodegeneration that Mimics Huntington’s Disease Modifies GABA-induced Currents

  2018cites this paper
• Zdhhc13-dependent Drp1 S-palmitoylation impacts brain bioenergetics, anxiety, coordination and motor skills

  2017cites this paper
• Tert-buthylhydroquinone pre-conditioning exerts dual effects in old female rats exposed to 3-nitropropionic acid

  2017cites this paper
• Regenerative medicine in Huntington's disease: Strengths and weaknesses of preclinical studies.

  2017cites this paper
• INCREASED STRIATAL VULNERABILITY TO 3-NITROPROPIONIC ACID IN MALE, BUT NOT FEMALE, MICE LACKING INTERLEUKIN-1R1

  2017influential citation
• 3-Nitropropionic acid production by the endophytic Diaporthe citri: Molecular taxonomy, chemical characterization, and quantification under pH variation.

  2016cites this paper
• Experience of experimental modelling of Huntington’s disease

  2016cites this paper
• Study the neuroprotective effect of tyrosol in an experimental model of huntington's disease as a subsidy for the development of new medicines

  2016cites this paper
• Heterogeneous nuclear ribonucleoprotein A1 post-transcriptionally regulates Drp1 expression in neuroblastoma cells

  2015cites this paper
• The N-Methyl-d-Aspartate Receptor Antagonist MK-801 Prevents Thallium-Induced Behavioral and Biochemical Alterations in the Rat Brain

  2015cites this paper
• Role of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats.

  2014cites this paper
• Estudo do Efeito Neuroprotetor do Eugenol em Modelo Experimental da Doença de Huntington

  2013cites this paper
• Probucol Increases Striatal Glutathione Peroxidase Activity and Protects against 3-Nitropropionic Acid-Induced Pro-Oxidative Damage in Rats

  2013cites this paper
• Stem cell‐based therapy for Huntington's disease

  2013cites this paper
• The effects of a single acute and repeated intracerebroventricular infusions of propionic acid on locomotor activity and neuroinflammation in rats

  2013cites this paper
• The Use of the Mitochondrial Toxin 3-NP to Uncover Cellular Dysfunction in Huntington’s Disease

  2012influential citation
• The spatial and temporal relationship between oxidative stress and neuronal degeneration in 3-nitropropionic acid model

  2012cites this paper
• Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity.

  2012cites this paper
• Glycogen accumulation in cardiomyocytes and cardiotoxic effects after 3NPA treatment.

  2012cites this paper
• SYSTEMS NEUROSCIENCE ORIGINAL RESEARCH ARTICLE

  2011cites this paper
• Huntington’s disease and mitochondrial alterations: emphasis on experimental models

  2010cites this paper
• 3-Nitropropionic Acid as a Tool to Study the Mechanisms Involved in Huntington’s Disease: Past, Present and Future

  2010cites this paper
• Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease

  2009cites this paper
• Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study

  2009influential citation
• N-Methyl-d-aspartate Receptor Antagonists Have Variable Affect in 3-Nitropropionic Acid Toxicity

  2009cites this paper
• [Model of Huntington's disease induced with 3-nitropropionic acid].

  2009cites this paper
• Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity.

  2008cites this paper
• Prolonged pretreatment with carvedilol prevents 3-nitropropionic acid-induced behavioral alterations and oxidative stress in rats.

  2008cites this paper
• Studies on the neurobehavioural toxic effects of the mitochondrial toxin, 3-nitropropionic acid

  2007cites this paper
• Animal models of Huntington's disease.

  2007cites this paper
• AAV-vector mediated gene delivery for Huntington's Disease : an investigative therapeutic study.

  2007influential citation
• S-Allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxidative stress and mitochondrial dysfunction.

  2006cites this paper
• Susceptibility to excitotoxic and metabolic striatal neurodegeneration in the mouse is genotype dependent.

  2005cites this paper
• Effects of 3-nitropropionic acid on the cortical and peripheral nervous activity in rats

  2005cites this paper
• Delayed effects of thallium in the rat brain: regional changes in lipid peroxidation and behavioral markers, but moderate alterations in antioxidants, after a single administration.

  2005cites this paper
• Animal Models of Neurological Disorders

  2005cites this paper
• LXIXth Annual Meeting of the Hungarian Physiological Society.

  2005cites this paper
• Behavioral alterations in lewis rats following two-day continuous 3-nitropropionic acid administration

  2005cites this paper
• 3‐Nitropropionic acid‐induced neurotoxicity – assessed by ultra high resolution positron emission tomography with comparison to magnetic resonance spectroscopy

  2004cites this paper
• _-Nitropropionic Acid in the Diet: Toxicity Aspects

  2004cites this paper
• Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats

  2003cites this paper
• Loss of cannabinoid CB1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington’s disease

  2002cites this paper
• Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease

  2002cites this paper
• Loss of cannabinoid CB(1) receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington's disease.

  2002cites this paper
• Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis.

  2002cites this paper
• Tier 1 Neurological Assessment in Regulated Animal Safety Studies

  2002cites this paper
• Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease.

  2001cites this paper
• Safety assessment of β-nitropropionic acid: a monograph in support of an acceptable daily intake in humans

  2001cites this paper
• Inhibition of glutamate uptake into synaptic vesicles from rat brain by 3-nitropropionic acid in vitro.

  2001cites this paper
• Behavioural correlates of striatal glial fibrillary acidic protein in the 3-nitropropionic acid rat model: disturbed walking pattern and spatial orientation.

  2001cites this paper
• Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene

  2000cites this paper
• Effect of Exogenous and Endogenous Antioxidants on 3‐Nitropionic Acid‐Inducedin vivo Oxidative Stress and Striatal Lesions

  2000cites this paper
• 3-nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease.

  2000cites this paper
• Neural Grafting for Parkinson’s and Huntington’s Disease

  2000cites this paper
• Neural Transplantation and Huntington’s Disease

  2000cites this paper
• Chronic cyclosporine-A injection in rats with damaged blood-brain barrier does not impair retention of passive avoidance.

  1998cites this paper
• Psychotropic and neurotropic activity

  1997cites this paper